临床试验参与者非裔仅占8%,美国医学种族主义令少数族裔对医疗系统失去信任_OK阅读网
双语新闻
Bilingual News


双语对照阅读
分级系列阅读
智能辅助阅读
在线英语学习
首页 |  双语新闻 |  双语读物 |  双语名著 | 
[英文] [中文] [双语对照] [双语交替]    []        


临床试验参与者非裔仅占8%,美国医学种族主义令少数族裔对医疗系统失去信任
Mistrust in U.S. medical system leads to lack of diversity in clinical trials

来源:中国日报    2023-02-09 09:00



        For decades, racial and ethnic minorities have been underrepresented in clinical trials even though they are disproportionately affected by several health issues such as diabetes and hypertension. According to the Robert A. Winn Diversity in Clinical Trials Award Program, 80% of individuals involved in clinical trials are white, compared to 58% in the U.S. population as a whole, which negatively affects the care that people of color receive.
        “If you look nationally, the number of folk of color [in clinical trials] are minuscule,” said Dr. Robert Winn, director of the Virginia Commonwealth University Massey Cancer Center, to Yahoo News.
        Studies estimate that Black Americans make up about 8% of participants in clinical trials but represent 13% of the U.S. population, and Hispanics account for 11% in trials, even though they are 16% of the national population.
        Not having that diversity in clinical trials prevents us from having information that can inform both patients, caregivers, and physicians around the appropriate medication that might be best for a particular patient,Maria Apostolaros, a deputy vice president at PhRMA, a biopharmaceutical research company, told Yahoo News.
        Experts say the lack of diversity in trials is due to a mistrust of the medical system by many underrepresented minority populations in the United States, and theres historical sort of events that have caused that,John Damonti, the president of Bristol Myers Squibb Foundation, which focuses on health equity, told Yahoo News.
        The most notable instance of medical racism occurred in 1932 when doctors from the United States Public Health Service embarked on the Tuskegee Syphilis Study in which hundreds of Black men were used as subjects for experimentation and research.
        Tuskegee is just one really terrible example but there have been so many examples of these kinds of abuses and clinical research throughout the years, especially here in the United States,Dr. Joshua Budhu, a neurologist at Memorial Sloan Kettering Cancer Center in New York City, told Yahoo News.
        “Now that we are creating therapies and creating trials that would also benefit people of color, we still have this leftover mistrust,” Winn said.
        For racial and ethnic minorities discrimination in health care is a problem that still plagues our society today. Over 40% of African American, Native American and Latinos have experienced unfair treatment in the medical field, according to a 2021 study by the Brookings Institute.
        Along with a lack of trust, doctors say minorities have trouble getting access to clinical trials. Were actually depriving people of first-line therapy,” Budhu said. One other kind of practical point about why clinical trial diversity is important is that it actually saves lots of money.
        A 2022 University of Southern California study found that clinical trials save lives and money. Health disparities in general cost trillions of dollars, but just by improving clinical trial diversity, which helps to decrease health disparities, it will actually save billions of dollars,” Budhu said.
        
   返回首页                  

OK阅读网 版权所有(C)2017 | 联系我们